| Announce Date | 11/25/2025 |
| EPS Normalized Actual | $0.76 (Beat by $0.65) |
| EPS GAAP Actual | $0.76 (Beat by $0.65) |
| Revenue Actual | $0.394637B |
| Revenue Surprise | Beat by $394.637M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.09 |
| EPS GAAP Estimate | $2.09 |
| Revenue Estimate | $0.46535B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2027 | 10.27 | 6.51 | 10.21753 | 10.34947 | 1 |
| Apr 2026 | 8.335 | 8.02 | 7.99951 | 8.68876 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.42 | -2.645 | 0.394637B | -14.66% | -110.96M |
| FQ3 2025 (Jul 2025) | 0 | -3 | 0B | -INF% | -507.7M |
| FQ2 2025 (Apr 2025) | 0 | -2.0875 | 0.400395B | -13.21% | -67.61M |
| FQ1 2025 (Jan 2025) | 1.1 | -0.45913 | 0.39758B | -6.17% | -7.15M |
| FQ4 2024 (Oct 2024) | 1.81 | 0.26859 | 0.452482B | -4.73% | -668.59M |
| FQ3 2024 (Jul 2024) | 1.91 | 1.91 | 0.459128B | -8.52% | 459.13M |
| FQ2 2024 (Apr 2024) | 0 | 0 | 0.453278B | -6.14% | 453.28M |
| FQ1 2024 (Jan 2024) | 1.32 | 1.32 | 0.422102B | -13.89% | 422.1M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
2.09
Consensus Revenue Estimates
0.46535B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 1.05333 | -- | 1.01722 | 1.09195 | 1 |
| FQ4 2026 (Oct 2026) | 2.495 | 83.17 | 2.43177 | 2.58491 | 1 |
| FQ3 2026 (Jul 2026) | 2.33 | -- | 2.27095 | 2.41396 | 1 |
| FQ2 2026 (May 2026) | 2.64667 | -- | 2.57128 | 2.7164 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.41B | -- | 0.4B | 0.42B | 2 |
| FQ4 2026 (Oct 2026) | 0.47B | 16.62 | 0.46B | 0.49B | 2 |
| FQ3 2026 (Jul 2026) | 0.46B | -- | 0.45B | 0.47B | 2 |
| FQ2 2026 (May 2026) | 0.49B | 18.53 | 0.48B | 0.5B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
3
Revenue # of Misses
5
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 3.065 | 0.42 | -2.645 | -629.76% |
| FQ3 2025 (Jul 2025) | 3 | 0 | -3 | -INF% |
| FQ2 2025 (Apr 2025) | 2.0875 | 0 | -2.0875 | -INF% |
| FQ1 2025 (Jan 2025) | 1.55913 | 1.1 | -0.45913 | -41.74% |
| FQ4 2024 (Oct 2024) | 1.54141 | 1.81 | 0.26859 | 14.84% |
| FQ3 2024 (Jul 2024) | 1.91 | 1.91 | 100% | |
| FQ2 2024 (Apr 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Jan 2024) | 1.32 | 1.32 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.51B | $0.39B | $-110.96M | -28.12% |
| FQ3 2025 (Jul 2025) | $0.51B | $0B | $-507.7M | -INF% |
| FQ2 2025 (Apr 2025) | $0.47B | $0.4B | $-67.61M | -16.89% |
| FQ1 2025 (Jan 2025) | $0.4B | $0.4B | $-7.15M | -1.8% |
| FQ4 2024 (Oct 2024) | $1.12B | $0.45B | $-668.59M | -147.76% |
| FQ3 2024 (Jul 2024) | $0B | $0.46B | $459.13M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.45B | $453.28M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.42B | $422.1M | 100% |